Szlovénia - szlovén - JAZMP (Javna agencija RS za zdravila in medicinske pripomočke)

kyowa kirin ltd. - fentanil - podjezična tableta - fentanil 600 µg / 1 tableta - fentanil

Szlovénia - szlovén - JAZMP (Javna agencija RS za zdravila in medicinske pripomočke)

roche d.o.o. - klonazepam - tableta - klonazepam 0,5 mg / 1 tableta - klonazepam

Szlovénia - szlovén - JAZMP (Javna agencija RS za zdravila in medicinske pripomočke)

roche d.o.o. - klonazepam - tableta - klonazepam 2 mg / 1 tableta - klonazepam

Szlovénia - szlovén - JAZMP (Javna agencija RS za zdravila in medicinske pripomočke)

kyowa kirin ltd. - fentanil - podjezična tableta - fentanil 800 µg / 1 tableta - fentanil

Európai Unió - szlovén - EMA (European Medicines Agency)

viatris limited - aflibercept - macular edema; retinal vein occlusion; diabetic retinopathy; myopia, degenerative; diabetes complications - oftalmologi - yesafili is indicated for adults for the treatment ofneovascular (wet) age-related macular degeneration (amd) (see section 5. 1),visual impairment due to macular oedema secondary to retinal vein occlusion (branch rvo or central rvo) (see section 5. 1),visual impairment due to diabetic macular oedema (dme) (see section 5. 1),visual impairment due to myopic choroidal neovascularisation (myopic cnv) (see section 5.

Európai Unió - szlovén - EMA (European Medicines Agency)

teva b.v. - topotekan - ovarian neoplasms; uterine cervical neoplasms; small cell lung carcinoma - antineoplastična sredstva - topotecan monotherapy is indicated for the treatment of: , patients with metastatic carcinoma of the ovary after failure of first line or subsequent therapy;, patients with relapsed small cell lung cancer [sclc] for whom re-treatment with the first-line regimen is not considered appropriate. , topotecan v kombinaciji z cisplatin je indicirano za bolnike z karcinom materničnega vratu periodično po radioterapija in za bolnike z stadiju ivb bolezni. bolniki s predhodno izpostavljenosti cisplatin zahtevajo trajno zdravljenje prosti interval, da se upraviči zdravljenje s kombinacijo.

Európai Unió - szlovén - EMA (European Medicines Agency)

gilead sciences international limited - cidofovir - citomegalovirusni retinitis - antivirusi za sistemsko uporabo - zdravilo vistide je indicirano za zdravljenje citomegalovirusnega retinitisa pri bolnikih s sindromom pridobljene imunske pomanjkljivosti (aids) in brez ledvične disfunkcije. zdravilo vistide je treba uporabljati le, če se druga zdravila štejejo za neprimerna.

Európai Unió - szlovén - EMA (European Medicines Agency)

glaxosmithkline (ireland) limited - belantamab mafodotin - multiple myeloma - antineoplastična sredstva - blenrep is indicated as monotherapy for the treatment of multiple myeloma in adult patients, who have received at least four prior therapies and whose disease is refractory to at least one proteasome inhibitor, one immunomodulatory agent, and an anti-cd38 monoclonal antibody, and who have demonstrated disease progression on the last therapy.

Európai Unió - szlovén - EMA (European Medicines Agency)

recordati rare diseases - merkaptamin hidroklorid - cistinoza - oftalmologi - cistadropus je indiciran za zdravljenje depozitov kristina roženice pri odraslih in otrocih, starih od 2 let, s cistinozo.

Európai Unió - szlovén - EMA (European Medicines Agency)

novartis europharm limited  - brolucizumab - mokra makularna degeneracija - oftalmologi - beovu je navedeno pri odraslih za zdravljenje neovascular (mokro) starostna degeneracija rumene pege (amd).